Your browser doesn't support javascript.
loading
The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma.
Zhang, Yu; Gao, Xiaomei; Zhu, Ying; Kadel, Dhruba; Sun, Haoran; Chen, Jing; Luo, Qin; Sun, Haoting; Yang, Luyu; Yang, Jing; Sheng, Yuanyuan; Zheng, Yan; Zhu, Kejin; Dong, Qiongzhu; Qin, Lunxiu.
Afiliação
  • Zhang Y; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Institutes of Biomedical Sciences, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China.
  • Gao X; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Institutes of Biomedical Sciences, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China.
  • Zhu Y; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Institutes of Biomedical Sciences, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China.
  • Kadel D; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Institutes of Biomedical Sciences, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China.
  • Sun H; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Institutes of Biomedical Sciences, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China.
  • Chen J; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Duke University, Durham, NC, USA.
  • Luo Q; Duke Cancer Institute, Duke University, Durham, NC, USA.
  • Sun H; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Institutes of Biomedical Sciences, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China.
  • Yang L; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Institutes of Biomedical Sciences, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China.
  • Yang J; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Institutes of Biomedical Sciences, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China.
  • Sheng Y; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Institutes of Biomedical Sciences, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China.
  • Zheng Y; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Institutes of Biomedical Sciences, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China.
  • Zhu K; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Institutes of Biomedical Sciences, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China.
  • Dong Q; Kanion Research Institute, 58 Kangyuan Road, Lianyungang, 222002, Jiangsu, China. kjzkanion@hotmail.com.
  • Qin L; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Institutes of Biomedical Sciences, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China. qzhdong@fudan.edu.cn.
J Exp Clin Cancer Res ; 37(1): 93, 2018 Apr 30.
Article em En | MEDLINE | ID: mdl-29712569

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Proteínas Proto-Oncogênicas c-met / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Proteínas Proto-Oncogênicas c-met / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China